4.6 Review

Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?

Journal

FEBS JOURNAL
Volume 280, Issue 17, Pages 4131-4148

Publisher

WILEY
DOI: 10.1111/febs.12338

Keywords

growth; atrophy; IL-6; inflammation; metabolism; myogenesis; myokine; regeneration; satellite cell; signaling pathway; skeletal muscle

Funding

  1. EU-FP7 (Myoage)
  2. MICINN [SAF2009-09782, FIS-PS09/01267, SAF2012-38547, PLE2009-0124, CIBERNED]
  3. AFM
  4. Fundacion Marato-TV3
  5. MDA
  6. EU-FP7 (Optistem and Endostem)
  7. Danish National Research Foundation [DNRF55]
  8. ICREA Funding Source: Custom

Ask authors/readers for more resources

Interleukin (IL)-6 is a cytokine with pleiotropic functions in different tissues and organs. Skeletal muscle produces and releases significant levels of IL-6 after prolonged exercise and is therefore considered as a myokine. Muscle is also an important target of the cytokine. IL-6 signaling has been associated with stimulation of hypertrophic muscle growth and myogenesis through regulation of the proliferative capacity of muscle stem cells. Additional beneficial effects of IL-6 include regulation of energy metabolism, which is related to the capacity of actively contracting muscle to synthesize and release IL-6. Paradoxically, deleterious actions for IL-6 have also been proposed, such as promotion of atrophy and muscle wasting. We review the current evidence for these apparently contradictory effects, the mechanisms involved and discuss their possible biological implications.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available